Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Seifert

Showing results (61-70 of 212) with videos related to

Pageof 22
Sort By:
The Journal of Family Practice|May 1, 1983
BotulismA B Sanders, S Seifert, M Kobernick
Vaccine|April 1, 1988
Alternative model for Neisseria gonorrhoeae pilin variationH S Seifert, R Ajioka, M So
Nuclear Medicine and Biology|November 1, 1995
Radiochemical purity of 99mTc-HM-PAO: critical parameters during kit preparationS Seifert, O Muth, K Jantsch, et al.
Nuclear Medicine Communications|October 22, 2003
Novel tumortropic ester derivatives of 99mTc(V) mesodimercapto succinic acid with low affinity for bone tissueS Seifert, R Syhre, H Spies, et al.
Zentralblatt Fur Chirurgie|August 10, 2000
[Stage-adapted therapy of pleural empyema. Results during 1992-1998]H Helfritzsch, T Lesser, S Seifert, et al.
The Journal of Emergency Medicine|January 1, 1985
Emergency department management of the sexual assault victimM E Kobernick, S Seifert, A B Sanders
Journal of Bacteriology|August 1, 1992
Construction of a Neisseria gonorrhoeae MS11 derivative deficient in NgoMI restriction and modificationD C Stein, R Chien, H S Seifert
Plos One|November 29, 2021
Health co-inquiry in migraine: Online participation and stakeholder experiences before and during the COVID-19 pandemicCamden L Baucke, Lauren S Seifert, Kara Kaelber
Gene|December 31, 1993
Transcriptional control of gonococcal pilE expression: involvement of an alternate sigma factorS Boyle-Vavra, M So, H S Seifert
Atherosclerosis|April 1, 1992
The apolipoprotein(a) moiety of lipoprotein(a) interacts with the complement activation fragment iC3b but does not functionally affect C3 activation or degradationP S Seifert, I Roth, T F Zioncheck
Pageof 22

Showing results (61-70 of 212) with videos related to

Sort By:
Pageof 22
The Journal of Family Practice|May 1, 1983
BotulismA B Sanders, S Seifert, M Kobernick
Vaccine|April 1, 1988
Alternative model for Neisseria gonorrhoeae pilin variationH S Seifert, R Ajioka, M So
Nuclear Medicine and Biology|November 1, 1995
Radiochemical purity of 99mTc-HM-PAO: critical parameters during kit preparationS Seifert, O Muth, K Jantsch, et al.
Nuclear Medicine Communications|October 22, 2003
Novel tumortropic ester derivatives of 99mTc(V) mesodimercapto succinic acid with low affinity for bone tissueS Seifert, R Syhre, H Spies, et al.
Zentralblatt Fur Chirurgie|August 10, 2000
[Stage-adapted therapy of pleural empyema. Results during 1992-1998]H Helfritzsch, T Lesser, S Seifert, et al.
The Journal of Emergency Medicine|January 1, 1985
Emergency department management of the sexual assault victimM E Kobernick, S Seifert, A B Sanders
Journal of Bacteriology|August 1, 1992
Construction of a Neisseria gonorrhoeae MS11 derivative deficient in NgoMI restriction and modificationD C Stein, R Chien, H S Seifert
Plos One|November 29, 2021
Health co-inquiry in migraine: Online participation and stakeholder experiences before and during the COVID-19 pandemicCamden L Baucke, Lauren S Seifert, Kara Kaelber
Gene|December 31, 1993
Transcriptional control of gonococcal pilE expression: involvement of an alternate sigma factorS Boyle-Vavra, M So, H S Seifert
Atherosclerosis|April 1, 1992
The apolipoprotein(a) moiety of lipoprotein(a) interacts with the complement activation fragment iC3b but does not functionally affect C3 activation or degradationP S Seifert, I Roth, T F Zioncheck
Pageof 22